Easywell Biomedicals, Inc.

NT$24.75As of Sun 8 Nov 2026, 12:00 UTC
TPEx:1799Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (3.23%)
Div yield —
ROE (2.10%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.05)
PE TTM —
TSR TTM (38.96%)
Mkt cap NT$3.086B
ROIC (0.16%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$30
20.05%
(45.54%)
Hold 1|0|4|6|0
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.26
0.28
0.28
0.29
13.68%
20.00%
24.38%
21.99%
RevenueNT$M
308.0
316.4
329.2
337.4
14.08%
13.49%
15.04%
14.45%
Peers (US$93.21M)
Cap (US$)
PE
83.10M
13.71x
78.24M
12.80x
Capital
TTM
5Y
10Y
Leveragex
0.336
0.069
0.067
EBIT/Intx
1.342
0.173
0.166
Own earn%
(6.95)
4.53
2.65
Sh yield%
24.92
24.60
22.88
Owners
Insiders/Inst%
6.23
44.15
Short interest%
3.33
SBC / revenue%
5.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
15–22
$1 testx
—
Incr. ROIC%
0